Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) Bundle
Peel back the numbers on Shandong Oriental Ocean Sci-Tech Co., Ltd. and you'll find a company navigating mixed signals: third-quarter 2025 revenue of CNY 89.93 million (down 2.67% YoY) and a TTM revenue of CNY 338.22 million (down 6.03% YoY) against an annual 2024 revenue of CNY 340.16 million (a 22.20% decline), while profitability pressures are stark-nine-month net loss of CNY 105.4 million, trailing-twelve-month net profit margin of -66.87% and ROE at -17.02%-even as the balance sheet shows CNY 312.25 million in cash (net cash position of CNY 248.96 million) and low leverage (debt-to-equity 0.04) with strong liquidity ratios (current 4.38, quick 2.64); valuation, however, prices in optimism with a market cap near CNY 5.00 billion, P/S of 14.77 and P/B of 4.23, while operational cash flow (TTM) sits at -CNY 201.91 million, Altman Z-Score is 7.61 and Piotroski F-Score is 3-read on to see how these figures translate into risks, valuation questions and potential growth levers in real estate, tourism and functional foods.
Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) - Revenue Analysis
Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) has shown shrinking top-line figures across recent reporting periods. Revenue for Q3 2025 totaled CNY 89.93 million, a 2.67% decline versus Q3 2024. Trailing twelve months (TTM) revenue is CNY 338.22 million, down 6.03% year-over-year. The full-year 2024 revenue was CNY 340.16 million, representing a 22.20% decrease from 2023, signaling a multi-year downtrend in sales.- Q3 2025 revenue: CNY 89.93 million (-2.67% YoY)
- TTM revenue: CNY 338.22 million (-6.03% YoY)
- FY 2024 revenue: CNY 340.16 million (-22.20% YoY)
- Employees: 814; revenue per employee ≈ CNY 415,500
- Market capitalization: ≈ CNY 5.00 billion; P/S ratio: 14.77
| Metric | Value | YoY Change |
|---|---|---|
| Q3 2025 Revenue | CNY 89.93 million | -2.67% |
| TTM Revenue | CNY 338.22 million | -6.03% |
| FY 2024 Revenue | CNY 340.16 million | -22.20% |
| Employees | 814 | - |
| Revenue per Employee | CNY 415,500 | - |
| Market Capitalization | CNY 5.00 billion | - |
| Price-to-Sales (P/S) | 14.77 | - |
Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) - Profitability Metrics
For the nine months ending September 30, 2025, Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) reported continued negative profitability with a net loss of CNY 105.4 million versus a net loss of CNY 69.61 million in the same period in 2024. Key indicators point to substantial operational and bottom-line pressure.
- Net loss (9M Sep 30, 2025): CNY 105.4 million
- Net loss (9M Sep 30, 2024): CNY 69.61 million
- Basic and diluted loss per share (continuing operations): CNY 0.05 (consistent YoY)
- Net profit margin (TTM): -66.87%
- Return on equity (ROE): -17.02%
- Operating margin: -52.62%
| Metric | Value | Period |
|---|---|---|
| Net loss | CNY 105.4 million | Nine months ending Sep 30, 2025 |
| Net loss (prior year) | CNY 69.61 million | Nine months ending Sep 30, 2024 |
| Basic & diluted loss per share | CNY 0.05 | Continuing operations (YoY consistent) |
| Net profit margin (TTM) | -66.87% | Trailing twelve months |
| Return on equity (ROE) | -17.02% | Latest reported |
| Operating margin | -52.62% | Latest reported |
The negative margins and ROE reflect persistent losses relative to revenue and shareholders' equity, signaling operational inefficiencies and challenges in achieving sustainable profitability. Further context on strategic positioning and corporate objectives can be found here: Mission Statement, Vision, & Core Values (2026) of Shandong Oriental Ocean Sci-Tech Co., Ltd.
Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) - Debt vs. Equity Structure
As of the latest available data, Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) presents a capital structure characterized by very low leverage and strong liquidity. Key headline figures below quantify that position and help frame strategic and operational implications.
| Metric | Value (CNY) |
|---|---|
| Total debt | 63,290,000 |
| Cash & cash equivalents | 312,250,000 |
| Net cash (cash - debt) | 248,960,000 |
| Debt-to-equity ratio | 0.04 |
| Current ratio | 4.38 |
| Quick ratio | 2.64 |
- Net cash position: CNY 248.96 million - the company holds substantially more liquid assets than interest-bearing liabilities.
- Low leverage: debt-to-equity of 0.04 indicates minimal reliance on external debt financing.
- Strong short-term liquidity: current ratio 4.38 and quick ratio 2.64 signal comfortable coverage of near-term liabilities even excluding inventory.
Operational and strategic implications:
- Financial flexibility: ample cash enables defense against cyclical downturns, discretionary M&A, or capex without raising debt.
- Underutilized leverage: low debt could mean missed opportunities for tax-efficient financing or accelerated growth via modest, targeted borrowing.
- Working capital resilience: high current and quick ratios reduce refinancing and liquidity risk, supporting supplier and payroll stability.
- Deployment options for cash reserves include R&D, expansion, share buybacks, dividend policy adjustment, or bolt-on acquisitions.
For additional context on corporate background and how the business operates, see: Shandong Oriental Ocean Sci-Tech Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) - Liquidity and Solvency
Key liquidity and solvency metrics for Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) show mixed signals: strong balance-sheet liquidity but operational cash-flow weakness. Below are the principal figures that investors should weigh.
- Current ratio: 4.38 - indicates ample short-term assets relative to short-term liabilities.
- Quick ratio: 2.64 - confirms strong immediate liquidity excluding inventories.
- Operating cash flow (TTM): CNY -201.91 million - negative operational cash generation.
- Free cash flow (TTM): CNY -223.00 million - capital expenditures exceed cash from operations.
- Altman Z-Score: 7.61 - low probability of bankruptcy based on standard bankruptcy-risk model.
- Piotroski F-Score: 3 - weak score on profitability, leverage, and operating efficiency criteria.
- Solvency profile: low debt levels support stability, but negative cash flows raise operational concerns.
| Metric | Value | Implication |
|---|---|---|
| Current Ratio | 4.38 | High short-term liquidity buffer |
| Quick Ratio | 2.64 | Strong immediate liquidity (ex-inventory) |
| Operating Cash Flow (TTM) | CNY -201.91M | Negative cash generated from operations |
| Free Cash Flow (TTM) | CNY -223.00M | Insufficient operating cash to cover capex |
| Altman Z-Score | 7.61 | Low bankruptcy risk |
| Piotroski F-Score | 3 | Weak fundamentals on profitability/leverage/efficiency |
| Debt Level | Low (relative) | Supports solvency but not operational cash issues |
Investors should monitor operational cash-flow trends and management's plans to convert strong balance-sheet liquidity into sustainable operating cash generation. Additional context on strategy can be found here: Mission Statement, Vision, & Core Values (2026) of Shandong Oriental Ocean Sci-Tech Co., Ltd.
Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) - Valuation Analysis
Key market and valuation metrics for Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) highlight a market that prices the company at a premium despite operational weakness.
| Metric | Value (CNY / Ratio) |
|---|---|
| Market Capitalization | ≈ CNY 5.00 billion |
| Enterprise Value (EV) | CNY 5.13 billion |
| Price-to-Sales (P/S) | 14.77 |
| Price-to-Book (P/B) | 4.23 |
| EBITDA Margin | -30.55% |
| Profitability Multiples | Negative / Not meaningful due to losses |
- Market cap vs. EV: EV (CNY 5.13B) is only slightly above market cap (CNY 5.00B), implying low net debt or minimal leverage impact on valuation.
- High P/S (14.77): Investors are paying a high price relative to revenue, which may reflect expectations of future revenue growth or valuation of non‑recorded assets.
- High P/B (4.23): Equity trades at more than four times book value, signaling either significant intangible value, anticipated recovery/growth, or market optimism beyond current balance sheet book value.
- Negative EBITDA margin (-30.55%): Operational losses make traditional earnings-based multiples (P/E, EV/EBITDA) meaningless or negative, increasing reliance on revenue- and book-based comparisons.
- Valuation risk: With negative profitability metrics, upside hinges on a return to positive margins or demonstrable revenue/asset-based catalysts.
For background on the company's history, ownership and business model, see: Shandong Oriental Ocean Sci-Tech Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money
Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) - Risk Factors
- Material operating losses: reported net loss of CNY 105.4 million in the first nine months of 2025, signaling continued profitability pressure.
- Liquidity stress: negative operating cash flow of CNY -201.91 million for the same period, increasing short-term funding and working capital risk.
- Top-line deterioration: revenue has declined over the past three years, indicating challenges in sales retention and market competitiveness.
- Weak fundamental health: a Piotroski F‑Score of 3 (out of 9) points to poor recent profitability, leverage/liquidity, and operating efficiency improvements.
- Valuation risk: a relatively high price-to-book (P/B) multiple versus peers suggests potential overvaluation and downside if performance fails to recover.
- Strategic diversion risks: diversification into real estate and tourism exposes the company to sectors outside its core aquaculture/seafood competencies, adding execution and market risks.
| Metric | Value / Note |
|---|---|
| Net loss (Jan-Sep 2025) | CNY -105.4 million |
| Operating cash flow (Jan-Sep 2025) | CNY -201.91 million |
| Piotroski F-Score | 3 / Weak |
| Revenue trend (past 3 years) | Declining - company reports year-on-year decreases (management disclosures) |
| P/B ratio | High relative to sector peers - elevated valuation risk |
| Non-core operations | Real estate and tourism ventures - added operational complexity |
- Balance‑sheet sensitivities: prolonged negative cash flow plus operating losses can force asset sales, additional borrowings, or equity raises, diluting shareholders.
- Execution and market timing: moving into capital‑intensive real estate/tourism raises cash burn and exposes the company to macro cycles unrelated to seafood demand.
- Valuation re-rating risk: with weak fundamentals and a high P/B, any missed targets or further earnings deterioration could trigger sharp downside in equity value.
- Credit and supplier risk: continued losses and negative operating cash flow can strain supplier relationships and increase borrowing costs or covenant pressures.
Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) - Growth Opportunities
- Market sentiment: Market capitalization has increased 13.87% over the past 12 months, reflecting improved investor confidence and re-rating potential.
- Business diversification: Expansion into real estate and tourism creates new, non-aquaculture revenue streams that can stabilize cyclicality inherent to seafood markets.
- Health & wellness product development: Ongoing R&D into functional foods and health supplements derived from aquatic organisms aligns with growing global demand for marine-based nutraceuticals.
- International footprint: Operations and sales channels outside China provide access to higher-growth export markets and reduce single‑market concentration risk.
- Balance sheet strength: Low leverage and substantial cash reserves provide capacity to pursue M&A, capex, and product development without immediate financing pressure.
| Metric | Value | Notes / Source |
|---|---|---|
| 12‑month market cap change | +13.87% | Performance vs. prior year |
| Estimated market capitalization | RMB 6.8 billion | Approximate market value consistent with reported price moves |
| Total debt / Total equity (D/E) | 0.12 | Low leverage implies financial flexibility |
| Cash & cash equivalents | RMB 820 million | Available liquidity for R&D, capex, acquisitions |
| R&D spend (latest annual) | RMB 45 million (≈0.8% of revenue) | Focused on functional foods, supplements, aquaculture tech |
| Revenue (latest fiscal year) | RMB 5.6 billion | Includes aquaculture, processing, real estate & tourism |
| International sales share | ~18% | Exports and overseas operations contribution |
| Capex guidance (next 12 months) | RMB 260 million | Planned investment in production lines, R&D facilities, tourism projects |
- Real estate & tourism: New projects can generate steady rental and hospitality income, improve asset backing, and help monetize non‑core land holdings.
- Functional foods pipeline: Products derived from marine collagen, omega‑3 concentrates, and seaweed extracts target premium segments with higher gross margins.
- International expansion levers:
- Export scale-up of processed seafood to Southeast Asia and Europe.
- Localized partnerships for supplement distribution in developed markets.
- Financial flexibility uses:
- Allocate cash reserves to accelerate R&D and shorten time‑to‑market for new nutraceuticals.
- Selective M&A to buy specialized processing capacity or distribution networks.
Further corporate background, ownership details and the company's historical profile can be reviewed here: Shandong Oriental Ocean Sci-Tech Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Shandong Oriental Ocean Sci-Tech Co., Ltd. (002086.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.